Cypress Capital Group Merck & Co., Inc. Transaction History
Cypress Capital Group
- $879 Million
- Q3 2024
A detailed history of Cypress Capital Group transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cypress Capital Group holds 45,883 shares of MRK stock, worth $4.16 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
45,883
Previous 44,591
2.9%
Holding current value
$4.16 Million
Previous $5.52 Million
5.62%
% of portfolio
0.59%
Previous 0.67%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,828Shares Held
1.87BCall Options Held
15.5MPut Options Held
13.6M-
Vanguard Group Inc Valley Forge, PA250MShares$22.7 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$10.8 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$6.88 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.37 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $230B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...